SCHOTT Pharma Inaugurates Expanded Vial Production Facility in Lebanon, Pennsylvania

SCHOTT Pharma inaugurated new production lines for standard and sterile ready-to-use glass vials at its Lebanon, Pennsylvania manufacturing facility on June 3, in a ribbon-cutting ceremony attended by Governor Josh Shapiro.

More than tripling U.S. vial capacity

The more than $60 million investment, largely funded by the U.S. Biomedical Advanced Research and Development Authority (BARDA), more than triples SCHOTT’s vial manufacturing capacity in the United States.

Supporting the domestic pharma supply chain

The new production lines are designed to support the domestic pharmaceutical packaging supply chain for biologics, vaccines, and injectable therapies. The Lebanon site is one of only two SCHOTT Pharma locations worldwide capable of manufacturing EVERIC pure vials.

Strengthening supply chain resilience

Christopher Cassidy, President of SCHOTT Pharma USA, said:

“We would like to express our sincere gratitude to the Biomedical Advanced Research and Development Authority for supporting the expansion of our U.S.-based manufacturing footprint. With its new advanced equipment, our site in Lebanon, Pennsylvania is strengthening supply chain resilience in the U.S. and ensuring the availability of primary packaging for critical life-saving therapies for patients throughout our nation.”